NUDCD3 Antibody

Total Page：16

File Type：pdf, Size：1020Kb

Efficient Professional Protein and Antibody Platforms NUDCD3 Antibody Basic information: Catalog No.: UPA61519 Source: Rabbit Size: 50ul/100ul Clonality: polyclonal Concentration: 1mg/ml Isotype: Rabbit IgG Purification: affinity purified by Protein A Useful Information: WB:1:500-2000 Applications: IHC-P:1:400-800 Reactivity: Human, Mouse, Rat, Pig Specificity: This antibody recognizes NUDCD3 protein. KLH conjugated synthetic peptide derived from human NUDCD3 Immunogen: 161-260/361 NUDCD3 functions to maintain the stability of dynein intermediate chain. Depletion of NUDCD3 results in aggregation and degradation of dynein in- Description: termediate chain, mislocalization of the dynein complex from kinetochores, spindle microtubules, and spindle poles, and loss of gamma-tubulin from spindle poles. NUDCD3 levels increase after the G1/S transition. Uniprot: Q8IVD9 Human BiowMW: 41 KDa Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Storage: Store at 4°C short term and -20°C long term. Avoid freeze-thaw cycles. Note: For research use only, not for use in diagnostic procedure. Data: Sample: U937 Cell (Human) Lysate at 30 ug Pri- mary: Anti- NUDCD3 at 1/300 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 41 kD Observed band size: 50 kD Gene Universal Technology Co. Ltd www.universalbiol.com Tel: 0550-3121009 E-mail: [email protected] Efficient Professional Protein and Antibody Platforms Sample: Hl-60 Cell (Human) Lysate at 30 ug Pri- mary: Anti- NUDCD3 at 1/300 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 41 kD Observed band size: 50 kD Paraformaldehyde-fixed, paraffin embedded at 37 ℃ for 30min; Antibody incubation with (NUDCD3) Polyclonal Antibody, Unconjugated at 1:400 overnight at 4℃, followed by operating according to SP Kit(Rabbit) instructionsand DAB staining. Gene Universal Technology Co. Ltd www.universalbiol.com Tel: 0550-3121009 E-mail: [email protected] .

Copy Link

Recommended publications

Table S8. Positively Selected Genes (Psgs) Identified in Glyptosternoid and Yellowhead Catfish Lineages
Table S8. positively selected genes (PSGs) identified in glyptosternoid and yellowhead catfish lineages. Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000000001 slc35a5 solute carrier family 35, member A5 0 0 G. maculatum ENSDARG00000000656 psmb9a proteasome (prosome, macropain) subunit, beta type, 9a 0 0 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde G. maculatum ENSDARG00000016649 akr7a3 0 0 reductase) G. maculatum ENSDARG00000017422 apmap adipocyte plasma membrane associated protein 0 0 G. maculatum ENSDARG00000003813 srp54 signal recognition particle 54 0 0 G. maculatum ENSDARG00000016173 cct3 chaperonin containing TCP1, subunit 3 (gamma) 0.012102523 0.049848505 G. maculatum ENSDARG00000018049 sf3b2 splicing factor 3b, subunit 2 0 0 G. maculatum ENSDARG00000004581 sel1l sel-1 suppressor of lin-12-like (C. elegans) 0.004079946 0.01759805 G. maculatum ENSDARG00000020344 slc2a8 solute carrier family 2 (facilitated glucose transporter), member 8 0.00E+00 0 G. maculatum ENSDARG00000011885 mrpl19 mitochondrial ribosomal protein L19 0 0 G. maculatum ENSDARG00000012640 cideb cell death-inducing DFFA-like effector b 0.00112672 0.005077819 G. maculatum ENSDARG00000003127 zgc:123105 zgc:123105 0 0 G. maculatum ENSDARG00000012929 eif2d eukaryotic translation initiation factor 2D 0.001049906 0.004752953 G. maculatum ENSDARG00000012947 SKA2 spindle and kinetochore associated complex subunit 2 0 0 G. maculatum ENSDARG00000015851 pnn pinin, desmosome associated protein 0 0 G. maculatum ENSDARG00000011418 sigmar1 sigma non-opioid intracellular receptor 1 0.00E+00 0 G. maculatum ENSDARG00000006926 btd biotinidase 0 0 G. maculatum ENSDARG00000012674 rpusd4 RNA pseudouridylate synthase domain containing 4 0.00E+00 0 G. maculatum ENSDARG00000017389 igfbp7 insulin-like growth factor binding protein 7 1.05E-02 0.043622349 G.
[Show full text]
Molecular Signatures Differentiate Immune States in Type 1 Diabetes Families
Page 1 of 65 Diabetes Molecular signatures differentiate immune states in Type 1 diabetes families Yi-Guang Chen1, Susanne M. Cabrera1, Shuang Jia1, Mary L. Kaldunski1, Joanna Kramer1, Sami Cheong2, Rhonda Geoffrey1, Mark F. Roethle1, Jeffrey E. Woodliff3, Carla J. Greenbaum4, Xujing Wang5, and Martin J. Hessner1 1The Max McGee National Research Center for Juvenile Diabetes, Children's Research Institute of Children's Hospital of Wisconsin, and Department of Pediatrics at the Medical College of Wisconsin Milwaukee, WI 53226, USA. 2The Department of Mathematical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. 3Flow Cytometry & Cell Separation Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907, USA. 4Diabetes Research Program, Benaroya Research Institute, Seattle, WA, 98101, USA. 5Systems Biology Center, the National Heart, Lung, and Blood Institute, the National Institutes of Health, Bethesda, MD 20824, USA. Corresponding author: Martin J. Hessner, Ph.D., The Department of Pediatrics, The Medical College of Wisconsin, Milwaukee, WI 53226, USA Tel: 011-1-414-955-4496; Fax: 011-1-414-955-6663; E-mail: [email protected]. Running title: Innate Inflammation in T1D Families Word count: 3999 Number of Tables: 1 Number of Figures: 7 1 For Peer Review Only Diabetes Publish Ahead of Print, published online April 23, 2014 Diabetes Page 2 of 65 ABSTRACT Mechanisms associated with Type 1 diabetes (T1D) development remain incompletely defined. Employing a sensitive array-based bioassay where patient plasma is used to induce transcriptional responses in healthy leukocytes, we previously reported disease-specific, partially IL-1 dependent, signatures associated with pre and recent onset (RO) T1D relative to unrelated healthy controls (uHC).
[Show full text]
Supplementary Information Supplementary Note
Supplementary Information Supplementary Note Bulk RNA Sequencing and Data Processing: Total RNAs from the dorsolateral prefrontal cortex (Brodmann area 8/9) of 208 brains from the FHS/BUADC study were extracted using the Promega Maxwell RSC simplyRNA Tissue Kit (Cat No# AS1340) according to the manufacturer’s protocol. The integrity and quality of RNA (RNA integrity number, RIN) was determined using the Agilent 2100 Bioanalyzer with RNA 600 Nano Chips (Cat No# 5067-1511). After excluding brain samples with RIN < 5, brain samples were randomized into seven library batches based on diagnosis, APOE genotype, sex, and RIN. Since there were only seven samples from AD cases with APOE genotypes 2/2 or 2/3, these specimens were included in batches 1 to 3 only. The BU Microarray & Sequencing Resource Core performed RNA sequencing (RNA-seq) library preparation. The libraries were prepared from total RNA enriched for mRNA using NEBNext Poly(A) mRNA Magnetic Isolation Module and NEBNext Ultra II Directional RNA Library Preparation Kit for Illumina (New England Biolabs, USA) and sequenced on an Illumina NextSeq 500 instrument (Illumina, USA). A total of 193 of the 208 samples remained for mapping after pre-processing. The average coverage of the remaining samples was 50 million reads for the entire sample. RNA-seq data from 193 FHS/BUADC brains were processed by our automated pipeline. We conducted quality control of the RNA-seq data for sequencing quality, over-abundance of adaptors, and over-represented sequence using the FastQC. Low-quality reads (5% of the total) were filtered out using the Trimmomatic option, which is a fast, multithreaded command line tool to trim and crop Illumina (FASTQ) data and remove adapters 1.
[Show full text]
Agricultural University of Athens
ΓΕΩΠΟΝΙΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΤΩΝ ΖΩΩΝ ΤΜΗΜΑ ΕΠΙΣΤΗΜΗΣ ΖΩΙΚΗΣ ΠΑΡΑΓΩΓΗΣ ΕΡΓΑΣΤΗΡΙΟ ΓΕΝΙΚΗΣ ΚΑΙ ΕΙΔΙΚΗΣ ΖΩΟΤΕΧΝΙΑΣ ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων ΕΙΡΗΝΗ Κ. ΤΑΡΣΑΝΗ ΕΠΙΒΛΕΠΩΝ ΚΑΘΗΓΗΤΗΣ: ΑΝΤΩΝΙΟΣ ΚΟΜΙΝΑΚΗΣ ΑΘΗΝΑ 2020 ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων Genome-wide association analysis and gene network analysis for (re)production traits in commercial broilers ΕΙΡΗΝΗ Κ. ΤΑΡΣΑΝΗ ΕΠΙΒΛΕΠΩΝ ΚΑΘΗΓΗΤΗΣ: ΑΝΤΩΝΙΟΣ ΚΟΜΙΝΑΚΗΣ Τριμελής Επιτροπή: Aντώνιος Κομινάκης (Αν. Καθ. ΓΠΑ) Ανδρέας Κράνης (Eρευν. B, Παν. Εδιμβούργου) Αριάδνη Χάγερ (Επ. Καθ. ΓΠΑ) Επταμελής εξεταστική επιτροπή: Aντώνιος Κομινάκης (Αν. Καθ. ΓΠΑ) Ανδρέας Κράνης (Eρευν. B, Παν. Εδιμβούργου) Αριάδνη Χάγερ (Επ. Καθ. ΓΠΑ) Πηνελόπη Μπεμπέλη (Καθ. ΓΠΑ) Δημήτριος Βλαχάκης (Επ. Καθ. ΓΠΑ) Ευάγγελος Ζωίδης (Επ.Καθ. ΓΠΑ) Γεώργιος Θεοδώρου (Επ.Καθ. ΓΠΑ) 2 Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων Περίληψη Σκοπός της παρούσας διδακτορικής διατριβής ήταν ο εντοπισμός γενετικών δεικτών και υποψηφίων γονιδίων που εμπλέκονται στο γενετικό έλεγχο δύο τυπικών πολυγονιδιακών ιδιοτήτων σε κρεοπαραγωγικά ορνίθια. Μία ιδιότητα σχετίζεται με την ανάπτυξη (σωματικό βάρος στις 35 ημέρες, ΣΒ) και η άλλη με την αναπαραγωγική
[Show full text]
Asante Et Al Dynein-2 Final Author Version
Asante, D. , Stevenson, N. L., & Stephens, D. J. (2014). Subunit composition of the human cytoplasmic dynein-2 complex. Journal of Cell Science, 127(21), 4774-4787. https://doi.org/10.1242/jcs.159038 Peer reviewed version Link to published version (if available): 10.1242/jcs.159038 Link to publication record in Explore Bristol Research PDF-document University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ SUBUNIT COMPOSITION OF THE HUMAN CYTOPLASMIC DYNEIN-2 COMPLEX. 1,2 1 DAVID ASANTE , NICOLA L. STEVENSON , AND DAVID J. STEPHENS* CELL BIOLOGY LABORATORIES, SCHOOL OF BIOCHEMISTRY, MEDICAL SCIENCES BUILDING, UNIVERSITY OF BRISTOL, BS8 1TD TEL: 00 44 117 331 2173 *CORRESPONDING AUTHOR. EMAIL: [email protected] 1 2 1 These authors contributed equally to this work. 2 PRESENT ADDRESS: MAMMALIAN GENETICS UNIT, MRC HARWELL, HARWELL SCIENCE AND INNOVATION CAMPUS, OXFORDSHIRE OX11 0RD, UK. KEYWORDS: MICROTUBULE MOTOR, DYNEIN, CILIA, INTRAFLAGELLAR TRANSPORT. 3 4 Number of words (not including references): 7608 5 SUMMARY 6 Cytoplasmic dynein-2 is the motor for retrograde intraflagellar transport and mutations in dynein-2 are known to cause 7 skeletal ciliopathies. Here we define for the first time the composition of the human cytoplasmic dynein-2 complex. We 8 show that the ciliopathy genes WDR34 and WDR60 are bona fide dynein-2 intermediate chains and are both required 9 for dynein-2 function.
[Show full text]
Single-Cell Analyses of Transcriptional Heterogeneity During Drug Tolerance
Single-cell analyses of transcriptional heterogeneity PNAS PLUS during drug tolerance transition in cancer cells by RNA sequencing Mei-Chong Wendy Leea,1, Fernando J. Lopez-Diazb,1, Shahid Yar Khana,2, Muhammad Akram Tariqa,3, Yelena Daync, Charles Joseph Vasked, Amie J. Radenbaugha, Hyunsung John Kima, Beverly M. Emersonb,4, and Nader Pourmanda,4 aBiomolecular Engineering Department, University of California, Santa Cruz, CA 95064; bLaboratory of Regulatory Biology, The Salk Institute for Biological Studies, La Jolla, CA 92037; cTransgenic Core Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; and dFive3 Genomics, LLC, Santa Cruz, CA 95060 Edited by Lewis T. Williams, Five Prime Therapeutics, Inc., South San Francisco, CA, and approved September 29, 2014 (received for review March 12, 2014) The acute cellular response to stress generates a subpopulation of resistance. Multiplexed single-cell quantitative PCR (qPCR) reversibly stress-tolerant cells under conditions that are lethal to assays allow expression-based analysis of up to 96 targets in the majority of the population. Stress tolerance is attributed to a single experiment (13). Recently, a few groups have demon- heterogeneity of gene expression within the population to ensure strated that RNA-Seq of single cells using NGS technology is survival of a minority. We performed whole transcriptome se- feasible, reproducible, and usable for gene expression-based quencing analyses of metastatic human breast cancer cells sub- classification of cell subpopulations (14–17). A major advantage jected to the chemotherapeutic agent paclitaxel at the single-cell of RNA-Seq in single-cell studies is that the entire transcriptome and population levels.
[Show full text]
Detection of H3k4me3 Identifies Neurohiv Signatures, Genomic
viruses Article Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis Liana Basova 1, Alexander Lindsey 1, Anne Marie McGovern 1, Ronald J. Ellis 2 and Maria Cecilia Garibaldi Marcondes 1,* 1 San Diego Biomedical Research Institute, San Diego, CA 92121, USA; [email protected] (L.B.); [email protected] (A.L.); [email protected] (A.M.M.) 2 Departments of Neurosciences and Psychiatry, University of California San Diego, San Diego, CA 92103, USA; [email protected] * Correspondence: [email protected] Abstract: Human postmortem specimens are extremely valuable resources for investigating trans- lational hypotheses. Tissue repositories collect clinically assessed specimens from people with and without HIV, including age, viral load, treatments, substance use patterns and cognitive functions. One challenge is the limited number of specimens suitable for transcriptional studies, mainly due to poor RNA quality resulting from long postmortem intervals. We hypothesized that epigenomic Citation: Basova, L.; Lindsey, A.; signatures would be more stable than RNA for assessing global changes associated with outcomes McGovern, A.M.; Ellis, R.J.; of interest. We found that H3K27Ac or RNA Polymerase (Pol) were not consistently detected by Marcondes, M.C.G. Detection of H3K4me3 Identifies NeuroHIV Chromatin Immunoprecipitation (ChIP), while the enhancer H3K4me3 histone modification was Signatures, Genomic Effects of abundant and stable up to the 72 h postmortem. We tested our ability to use H3K4me3 in human Methamphetamine and Addiction prefrontal cortex from HIV+ individuals meeting criteria for methamphetamine use disorder or not Pathways in Postmortem HIV+ Brain (Meth +/−) which exhibited poor RNA quality and were not suitable for transcriptional profiling.
[Show full text]
Identification of Novel Regulatory Genes in Acetaminophen
IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN A THESIS IN Cell Biology and Biophysics and Bioinformatics Presented to the Faculty of the University of Missouri-Kansas City in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY By KATHERINE ANNE SHORTT B.S, Indiana University, Bloomington, 2011 M.S, University of Missouri, Kansas City, 2014 Kansas City, Missouri 2018 © 2018 Katherine Shortt All Rights Reserved IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN Katherine Anne Shortt, Candidate for the Doctor of Philosophy degree, University of Missouri-Kansas City, 2018 ABSTRACT Acetaminophen (APAP) is a commonly used analgesic responsible for over 56,000 overdose-related emergency room visits annually. A long asymptomatic period and limited treatment options result in a high rate of liver failure, generally resulting in either organ transplant or mortality. The underlying molecular mechanisms of injury are not well understood and effective therapy is limited. Identification of previously unknown genetic risk factors would provide new mechanistic insights and new therapeutic targets for APAP induced hepatocyte toxicity or liver injury. This study used a genome-wide CRISPR/Cas9 screen to evaluate genes that are protective against or cause susceptibility to APAP-induced liver injury. HuH7 human hepatocellular carcinoma cells containing CRISPR/Cas9 gene knockouts were treated with 15mM APAP for 30 minutes to 4 days. A gene expression profile was developed based on the 1) top screening hits, 2) overlap with gene expression data of APAP overdosed human patients, and 3) biological interpretation including assessment of known and suspected iii APAP-associated genes and their therapeutic potential, predicted affected biological pathways, and functionally validated candidate genes.
[Show full text]
Increased DNA Methylation Variability in Rheumatoid Arthritis Discordant Monozygotic Twins
bioRxiv preprint doi: https://doi.org/10.1101/314963; this version posted May 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Increased DNA methylation variability in rheumatoid arthritis discordant monozygotic twins Amy P. Webster1,2*, Darren Plant3, Simone Ecker2, Flore Zufferey4, Jordana T. Bell4, Andrew Feber2, Dirk S. Paul5,6, Stephan Beck2, Anne Barton1,3, Frances M.K. Williams4#, Jane Worthington1,3#* 1 Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK 2 Department of Cancer Biology, UCL Cancer Institute, University College London, London, UK 3 NIHR Manchester Biomedical Research Centre, Manchester Academy of Health Sciences, Manchester University Foundation Trust, Manchester, UK 4 Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK 5 MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK 6 Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK #Joint senior authors * Corresponding authors: Professor Jane Worthington Email: [email protected] Telephone: +44 (0)161 275 5651 Fax: +44 (0)161 275 5043 Dr Amy P Webster Email: [email protected] Telephone: +44 (0)20 7679 6004 bioRxiv preprint doi: https://doi.org/10.1101/314963; this version posted May 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
[Show full text]
Clinical Efficacy and Immune Regulation with Peanut Oral
Clinical efficacy and immune regulation with peanut oral immunotherapy Stacie M. Jones, MD,a Laurent Pons, PhD,b Joseph L. Roberts, MD, PhD,b Amy M. Scurlock, MD,a Tamara T. Perry, MD,a Mike Kulis, PhD,b Wayne G. Shreffler, MD, PhD,c Pamela Steele, CPNP,b Karen A. Henry, RN,a Margaret Adair, MD,b James M. Francis, PhD,d Stephen Durham, MD,d Brian P. Vickery, MD,b Xiaoping Zhong, MD, PhD,b and A. Wesley Burks, MDb Little Rock, Ark, Durham, NC, New York, NY, and London, United Kingdom Background: Oral immunotherapy (OIT) has been thought to noted during OIT resolved spontaneously or with induce clinical desensitization to allergenic foods, but trials antihistamines. By 6 months, titrated skin prick tests and coupling the clinical response and immunologic effects of peanut activation of basophils significantly declined. Peanut-specific OIT have not been reported. IgE decreased by 12 to 18 months, whereas IgG4 increased Objective: The study objective was to investigate the clinical significantly. Serum factors inhibited IgE–peanut complex efficacy and immunologic changes associated with OIT. formation in an IgE-facilitated allergen binding assay. Secretion Methods: Children with peanut allergy underwent an OIT of IL-10, IL-5, IFN-g, and TNF-a from PBMCs increased over protocol including initial day escalation, buildup, and a period of 6 to 12 months. Peanut-specific forkhead box protein maintenance phases, and then oral food challenge. Clinical 3 T cells increased until 12 months and decreased thereafter. In response and immunologic changes were evaluated. addition, T-cell microarrays showed downregulation of genes in Results: Of 29 subjects who completed the protocol, 27 ingested apoptotic pathways.
[Show full text]
Proteomics-Based Insights Into Mitogen-Activated Protein Kinase
Zila et al. Clin Proteom (2018) 15:13 https://doi.org/10.1186/s12014-018-9189-x Clinical Proteomics RESEARCH Open Access Proteomics‑based insights into mitogen‑activated protein kinase inhibitor resistance of cerebral melanoma metastases Nina Zila1,2,3, Andrea Bileck2, Besnik Muqaku2, Lukas Janker2, Ossia M. Eichhof4, Phil F. Cheng4, Reinhard Dummer4, Mitchell P. Levesque4, Christopher Gerner2 and Verena Paulitschke1,4* Abstract Background: MAP kinase inhibitor (MAPKi) therapy for BRAF mutated melanoma is characterized by high response rates but development of drug resistance within a median progression-free survival (PFS) of 9–12 months. Under- standing mechanisms of resistance and identifying efective therapeutic alternatives is one of the most important scientifc challenges in melanoma. Using proteomics, we want to specifcally gain insight into the pathophysiological process of cerebral metastases. Methods: Cerebral metastases from melanoma patients were initially analyzed by a LC–MS shotgun approach per- formed on a QExactive HF hybrid quadrupole-orbitrap mass spectrometer. For further validation steps after bioinfor- matics analysis, a targeted LC-QQQ-MS approach, as well as Western blot, immunohistochemistry and immunocyto- chemistry was performed. Results: In this pilot study, we were able to identify 5977 proteins by LC–MS analysis (data are available via ProteomeXchange with identifer PXD007592). Based on PFS, samples were classifed into good responders (PFS 6 months) and poor responders (PFS ≤ 3 months). By evaluating these proteomic profles according to gene ontology≥ (GO) terms, KEGG pathways and gene set enrichment analysis (GSEA), we could characterize diferences between the two distinct groups. We detected an EMT feature (up-regulation of N-cadherin) as classifer between the two groups, V-type proton ATPases, cell adhesion proteins and several transporter and exchanger proteins to be signifcantly up-regulated in poor responding patients, whereas good responders showed an immune activation, among other features.
[Show full text]
UC Santa Cruz UC Santa Cruz Electronic Theses and Dissertations
UC Santa Cruz UC Santa Cruz Electronic Theses and Dissertations Title Single-Cell Analyses Of Transcriptional Heterogeneity During Drug Tolerance Transition In Cancer Cells By Rna Sequencing Permalink https://escholarship.org/uc/item/22f219xb Author Lee, Mei-Chong Wendy Publication Date 2014 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA SANTA CRUZ SINGLE-CELL ANALYSES OF TRANSCRIPTIONAL HETEROGENEITY DURING DRUG TOLERANCE TRANSITION IN CANCER CELLS BY RNA SEQUENCING A dissertation submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOINFORMATICS by Mei-Chong Wendy Lee December 2014 The dissertation of Mei-Chong Wendy Lee is approved by: Professor Nader Pourmand, Chair Professor Kevin Karplus Professor Rohinton Kamakaka Dietlind L Gerloff, PhD Dean Tyrus Miller Vice Provost and Dean of Graduate Studies Copyright c by Mei-Chong Wendy Lee 2014 Table of Contents List of Figures vi List of Tables viii Abstract ix Dedication xi Acknowledgments xii 1 Introduction 1 2 Background 5 2.1 Single-cell RNA Sequencing . 5 2.1.1 Single-cell RNA-Seq techniques using PCR technology . 6 2.1.2 Single-cell RNA-Seq techniques with an in-vitro transcription tech- nology . 11 2.1.3 Microﬂuidic Single-cell Preparation for RNA-Seq . 12 2.2 Commercially Available Single-cell RNA Ampliﬁcation Methods . 15 2.2.1 NuGEN Ovation RNA-Seq System . 15 2.2.2 2.2.2 Clontech SMARTer Ultra Low RNA Kit . 18 2.2.3 Sigma Transplex WTA2-SEQ Kit . 18 TM 2.2.4 Magnetic µMACS SuperAmp Kit by Miltenyi Biotec .
[Show full text]